EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group

Industry Body Raises The Alarm Over Energy Costs In Open Letter

Industry body Medicines for Europe is calling for pharmaceutical manufacturers to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. It warns that inflation and energy costs threaten European drug makers with closures and rationing.

Close up of capsules on a production line
European manufacturing needs support over rising energy costs • Source: Shutterstock

The generics and biosimilars industry body, Medicines For Europe, has demanded urgent economic support for pharmaceutical manufacturers in an open letter from association president Elisabeth Stampa to European energy ministers and European commissioners .

The letter asserts that surging inflation and input costs after the COVID-19 pandemic and Russia’s invasion of Ukraine have exacerbated an

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography